Allied Biotech Corporation

Informe acción TPEX:1780

Capitalización de mercado: NT$1.6b

Allied Biotech Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Qing Hui Lin

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO1.0%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?

Apr 16
Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?

These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well

Mar 05
These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well

Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment

Jan 24
Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment

Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?

Jan 03
Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?

A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)

Dec 13
A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)

Is Allied Biotech (GTSM:1780) A Risky Investment?

Nov 25
Is Allied Biotech (GTSM:1780) A Risky Investment?

CEO

Qing Hui Lin

no data

Permanencia

Qing Hui Lin is the Chief Executive Officer and Director of Allied Biotech Corporation.